person · Reporting owner
Caldwell Christopher A
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Concentrix CorpCNXC · Entity 4519 | Director · President and CEO | July 08, 2026 | July 09, 2026 |
| TD SYNNEX CORPSNX · Entity 8882 | President, Concentrix | October 20, 2020 | October 22, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Concentrix Corp
Report date July 08, 2026 · Filed July 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 358,382 |
Reported balance
After 2026-07-08 transaction · row 1
1 source rowRow 1 · 2026-07-08 · Purchase · Acquired 1,000 · Balance 358,382 |
TD SYNNEX CORP
Report date October 20, 2020 · Filed October 22, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,946 |
Ending reported balance
After 2020-10-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-10-20 · Grant · Acquired 9,389 · Balance 47,846 F1: Represents shares issued upon vesting of restricted stock units awarded on October 20, 2017 subject to satisfaction of performance metrics measured over a three-year period ended August 31, 2020 and continued employment through October 20, 2020. Row 2 · 2020-10-20 · Tax withholding · Disposed 4,900 · Balance 42,946 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issued upon vesting of restricted stock units awarded on October 20, 2017 subject to satisfaction of performance metrics measured over a three-year period ended August 31, 2020 and continued employment through October 20, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2022 Filed Jan 28, 2022 23:51 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 16,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-22-000031 · wf-form4_164341389222713.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,318 F1 · kind: Represents shares of restricted stock awarded under the 2020 Stock Incentive Plan. The restricted stock vests as to 25% of the shares on each of the first four anniversaries of the grant date. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 22:44 UTC | Concentrix Corp CNXC · Entity 4519 | Tax withholdingCommon Stock | 6,574 | $164.74 | $1,083,000.76 |
DisclosureSEC source: 0001803599-21-000206 · wf-form4_163857143639436.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,782 Read SEC document |
| October 20, 2021 Filed Oct 22, 2021 22:57 UTC | Concentrix Corp CNXC · Entity 4519 | Tax withholdingCommon Stock | 5,592 | $184.27 | $1,030,437.84 |
DisclosureSEC source: 0001803599-21-000189 · wf-form4_163494343884498.xml · nonDerivative · entry 2 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,356 Read SEC document |
| October 20, 2021 Filed Oct 22, 2021 22:57 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 14,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-21-000189 · wf-form4_163494343884498.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,948 F1 · kind: Represents shares issued upon vesting of restricted stock units awarded on October 20, 2017 subject to satisfaction of performance metrics measured over a three-year period ended August 31, 2020 and continued employment through October 20, 2021. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 22:56 UTC | Concentrix Corp CNXC · Entity 4519 | Tax withholdingCommon Stock | 570 | $179.88 | $102,531.60 |
DisclosureSEC source: 0001803599-21-000183 · wf-form4_163416579048125.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,739 Read SEC document |
| October 07, 2021 Filed Oct 12, 2021 22:53 UTC | Concentrix Corp CNXC · Entity 4519 | Tax withholdingCommon Stock | 362 | $181.50 | $65,703.00 |
DisclosureSEC source: 0001803599-21-000174 · wf-form4_163407920289797.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,309 Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:36 UTC | Concentrix Corp CNXC · Entity 4519 | Tax withholdingCommon Stock | 237 | $174.94 | $41,460.78 |
DisclosureSEC source: 0001803599-21-000154 · wf-form4_163348416135678.xml · nonDerivative · entry 3 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,671 Read SEC document |
| October 03, 2021 Filed Oct 6, 2021 01:36 UTC | Concentrix Corp CNXC · Entity 4519 | Tax withholdingCommon Stock | 207 | $174.94 | $36,212.58 |
DisclosureSEC source: 0001803599-21-000154 · wf-form4_163348416135678.xml · nonDerivative · entry 2 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,908 Read SEC document |
| October 02, 2021 Filed Oct 6, 2021 01:36 UTC | Concentrix Corp CNXC · Entity 4519 | Tax withholdingCommon Stock | 392 | $174.94 | $68,576.48 |
DisclosureSEC source: 0001803599-21-000154 · wf-form4_163348416135678.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,115 Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:16 UTC | Concentrix Corp CNXC · Entity 4519 | Tax withholdingCommon Stock | 32,243 | $151.10 | $4,871,917.30 |
DisclosureSEC source: 0001803599-21-000106 · wf-form4_162275496226938.xml · nonDerivative · entry 2 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,507 Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:16 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 65,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-21-000106 · wf-form4_162275496226938.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,750 F1 · kind: Represents shares issued upon the vesting of performance-based restricted stock units awarded on July 19, 2019. The restricted stock units vested six months following the December 1, 2020 effective date of the spin-off of the Issuer from SYNNEX Corporation. Read SEC document |
| January 28, 2021 Filed Feb 1, 2021 23:37 UTC | Concentrix Corp CNXC · Entity 4519 | Tax withholdingCommon Stock | 1,997 | $116.35 | $232,350.95 |
DisclosureSEC source: 0001803599-21-000038 · wf-form4_161222264111831.xml · nonDerivative · entry 2 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,718 Read SEC document |
| January 28, 2021 Filed Feb 1, 2021 23:37 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 5,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-21-000038 · wf-form4_161222264111831.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,715 F1 · kind: Represents shares issued upon the vesting of restricted stock units awarded on February 14, 2018 subject to the satisfaction of performance metrics measured over a three-year period ending November 30, 2020. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:21 UTC | Concentrix Corp CNXC · Entity 4519 | GrantEmployee Stock Option (Right to Buy) · Derivative | 26,212 | $0.00 Strike: $119.72 | $0.00 |
DisclosureSEC source: 0001803599-21-000025 · wf-form4_161135408559847.xml · derivative · entry 3 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,212 Underlying: Common Stock · 26,212 shares Expires 2031-01-20 F3 · derivative.exercise_date: This stock option vests as to 20% of the shares on the first anniversary of October 7, 2020 and vests as to 1/60th of the shares monthly thereafter. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:21 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 4,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-21-000025 · wf-form4_161135408559847.xml · nonDerivative · entry 2 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,068 F2 · kind: Represents shares of restricted stock awarded under the 2020 Stock Incentive Plan. The restricted stock vests as to 20% of the shares on each of the first five anniversaries of October 7, 2020. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:21 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 83,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-21-000025 · wf-form4_161135408559847.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,474 F1 · kind: Represents shares of restricted stock awarded under the 2020 Stock Incentive Plan. The restricted stock vests as to 20% of the shares on each of the first five anniversaries of December 1, 2020. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:45 UTC | Concentrix Corp CNXC · Entity 4519 | OtherEmployee Stock Option (Right to Buy) · Derivative | 30,057 | $0.00 Strike: $110.44 | $0.00 |
DisclosureSEC source: 0001803599-20-000050 · wf-form4_160703909794350.xml · derivative · entry 7 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,057 Underlying: Common Stock · 30,057 shares Expires 2029-10-02 F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known. F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known. F6 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 2, 2020, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:45 UTC | Concentrix Corp CNXC · Entity 4519 | OtherEmployee Stock Option (Right to Buy) · Derivative | 45,808 | $0.00 Strike: $76.01 | $0.00 |
DisclosureSEC source: 0001803599-20-000050 · wf-form4_160703909794350.xml · derivative · entry 6 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,808 Underlying: Common Stock · 45,808 shares Expires 2028-10-11 F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known. F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known. F5 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 11, 2019, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:45 UTC | Concentrix Corp CNXC · Entity 4519 | OtherEmployee Stock Option (Right to Buy) · Derivative | 11,172 | $0.00 Strike: $128.67 | $0.00 |
DisclosureSEC source: 0001803599-20-000050 · wf-form4_160703909794350.xml · derivative · entry 5 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,172 Underlying: Common Stock · 11,172 shares Expires 2027-10-03 F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known. F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known. F4 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 3, 2018, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:45 UTC | Concentrix Corp CNXC · Entity 4519 | OtherEmployee Stock Option (Right to Buy) · Derivative | 12,630 | $0.00 Strike: $112.08 | $0.00 |
DisclosureSEC source: 0001803599-20-000050 · wf-form4_160703909794350.xml · derivative · entry 4 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,630 Underlying: Common Stock · 12,630 shares Expires 2026-10-04 F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known. F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known. F3 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 4, 2017, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:45 UTC | Concentrix Corp CNXC · Entity 4519 | OtherEmployee Stock Option (Right to Buy) · Derivative | 9,363 | $0.00 Strike: $89.21 | $0.00 |
DisclosureSEC source: 0001803599-20-000050 · wf-form4_160703909794350.xml · derivative · entry 3 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,363 Underlying: Common Stock · 9,363 shares Expires 2025-10-06 F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known. F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:45 UTC | Concentrix Corp CNXC · Entity 4519 | OtherEmployee Stock Option (Right to Buy) · Derivative | 12,928 | $0.00 Strike: $62.90 | $0.00 |
DisclosureSEC source: 0001803599-20-000050 · wf-form4_160703909794350.xml · derivative · entry 2 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,928 Underlying: Common Stock · 12,928 shares Expires 2024-10-07 F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known. F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:45 UTC | Concentrix Corp CNXC · Entity 4519 | OtherCommon Stock | 42,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-20-000050 · wf-form4_160703909794350.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,946 F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX"), on December 1, 2020, SYNNEX distributed all of the issued and outstanding shares of Concentrix common stock to SYNNEX stockholders (the "Distribution"). SYNNEX stockholders received one share of Concentrix common stock for each share of SYNNEX common stock held as of the close of business on November 17, 2020. The number of shares of Concentrix common stock reported as acquired on this Form 4 reflects the number of shares of Concentrix common stock, including shares of restricted stock, acquired by the reporting person pursuant to the Distribution. Read SEC document |
| December 01, 2020 Filed Dec 8, 2020 00:35 UTC Amendment | Concentrix Corp CNXC · Entity 4519 | OtherEmployee Stock Option (Right to Buy) · Derivative | 30,057 | $0.00 Strike: $55.12 | $0.00 |
DisclosureSEC source: 0001803599-20-000059 · wf-form4a_160738770908800.xml · derivative · entry 6 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,057 Underlying: Common Stock · 30,057 shares Expires 2029-10-02 F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price. F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price. F5 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 2, 2020, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter. Read SEC document |
| December 01, 2020 Filed Dec 8, 2020 00:35 UTC Amendment | Concentrix Corp CNXC · Entity 4519 | OtherEmployee Stock Option (Right to Buy) · Derivative | 45,808 | $0.00 Strike: $37.94 | $0.00 |
DisclosureSEC source: 0001803599-20-000059 · wf-form4a_160738770908800.xml · derivative · entry 5 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,808 Underlying: Common Stock · 45,808 shares Expires 2028-10-11 F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price. F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price. F4 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 11, 2019, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter. Read SEC document |
| December 01, 2020 Filed Dec 8, 2020 00:35 UTC Amendment | Concentrix Corp CNXC · Entity 4519 | OtherEmployee Stock Option (Right to Buy) · Derivative | 11,172 | $0.00 Strike: $64.21 | $0.00 |
DisclosureSEC source: 0001803599-20-000059 · wf-form4a_160738770908800.xml · derivative · entry 4 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,172 Underlying: Common Stock · 11,172 shares Expires 2027-10-03 F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price. F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price. F3 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 3, 2018, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter. Read SEC document |
| December 01, 2020 Filed Dec 8, 2020 00:35 UTC Amendment | Concentrix Corp CNXC · Entity 4519 | OtherEmployee Stock Option (Right to Buy) · Derivative | 12,630 | $0.00 Strike: $55.94 | $0.00 |
DisclosureSEC source: 0001803599-20-000059 · wf-form4a_160738770908800.xml · derivative · entry 3 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,630 Underlying: Common Stock · 12,630 shares Expires 2026-10-04 F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price. F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price. F2 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 4, 2017, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter. Read SEC document |
| December 01, 2020 Filed Dec 8, 2020 00:35 UTC Amendment | Concentrix Corp CNXC · Entity 4519 | OtherEmployee Stock Option (Right to Buy) · Derivative | 9,363 | $0.00 Strike: $44.52 | $0.00 |
DisclosureSEC source: 0001803599-20-000059 · wf-form4a_160738770908800.xml · derivative · entry 2 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,363 Underlying: Common Stock · 9,363 shares Expires 2025-10-06 F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price. F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price. Read SEC document |
| December 01, 2020 Filed Dec 8, 2020 00:35 UTC Amendment | Concentrix Corp CNXC · Entity 4519 | OtherEmployee Stock Option (Right to Buy) · Derivative | 12,928 | $0.00 Strike: $31.39 | $0.00 |
DisclosureSEC source: 0001803599-20-000059 · wf-form4a_160738770908800.xml · derivative · entry 1 Caldwell Christopher A · CIK 0001604279 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,928 Underlying: Common Stock · 12,928 shares Expires 2024-10-07 F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price. F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 21:46 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 4,900 | $147.21 | $721,329.00 |
DisclosureSEC source: 0001127602-20-027423 · form4.xml · nonDerivative · entry 2 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,946 Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 21:46 UTC | TD SYNNEX CORP SNX · Entity 8882 | GrantCommon Stock | 9,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-027423 · form4.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,846 F1 · kind: Represents shares issued upon vesting of restricted stock units awarded on October 20, 2017 subject to satisfaction of performance metrics measured over a three-year period ended August 31, 2020 and continued employment through October 20, 2020. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 20:30 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 756 | $150.47 | $113,755.32 |
DisclosureSEC source: 0001127602-20-026931 · form4.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,457 Read SEC document |
| October 06, 2020 Filed Oct 7, 2020 20:55 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 234 | $151.92 | $35,549.28 |
DisclosureSEC source: 0001127602-20-026681 · form4.xml · nonDerivative · entry 3 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,213 Read SEC document |
| October 04, 2020 Filed Oct 7, 2020 20:55 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 315 | $150.60 | $47,439.00 |
DisclosureSEC source: 0001127602-20-026681 · form4.xml · nonDerivative · entry 2 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,447 Read SEC document |
| October 03, 2020 Filed Oct 7, 2020 20:55 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 264 | $150.60 | $39,758.40 |
DisclosureSEC source: 0001127602-20-026681 · form4.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,762 Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 20:49 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 375 | $147.64 | $55,365.00 |
DisclosureSEC source: 0001127602-20-026550 · form4.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,026 Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 19:57 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 1,212 | $140.09 | $169,789.08 |
DisclosureSEC source: 0001127602-20-003069 · form4.xml · nonDerivative · entry 2 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,401 Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 19:57 UTC | TD SYNNEX CORP SNX · Entity 8882 | GrantCommon Stock | 3,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-003069 · form4.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,613 F1 · kind: Represents shares issued upon vesting of restricted stock units awarded on January 27, 2017, subject to satisfaction of performance metrics measured over a three-year period ending November 31, 2019. Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 15:59 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 544 | $113.77 | $61,890.88 |
DisclosureSEC source: 0001127602-19-030479 · form4.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,487 Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 19:56 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 169 | $113.00 | $19,097.00 |
DisclosureSEC source: 0001127602-19-030311 · form4.xml · nonDerivative · entry 2 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,031 Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 19:56 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 239 | $113.00 | $27,007.00 |
DisclosureSEC source: 0001127602-19-030311 · form4.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,200 Read SEC document |
| October 04, 2019 Filed Oct 8, 2019 16:44 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 227 | $111.79 | $25,376.33 |
DisclosureSEC source: 0001127602-19-030248 · form4.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,439 Read SEC document |
| October 03, 2019 Filed Oct 7, 2019 15:51 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 198 | $110.11 | $21,801.78 |
DisclosureSEC source: 0001127602-19-030202 · form4.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,666 Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 22:54 UTC | TD SYNNEX CORP SNX · Entity 8882 | GrantEmployee Stock Option (Right to Buy) · Derivative | 30,057 | $0.00 Strike: $110.44 | $0.00 |
DisclosureSEC source: 0001127602-19-030171 · form4.xml · derivative · entry 2 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,057 Underlying: Common Stock · 30,057 shares Expires 2029-10-02 F2 · derivative.exercise_date: This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter. Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 22:54 UTC | TD SYNNEX CORP SNX · Entity 8882 | GrantCommon Stock | 4,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030171 · form4.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,864 F1 · kind: Represents shares of restricted stock awarded under the 2013 Stock Incentive Plan. The restricted stock vests as to 20% of the shares on each of the first five anniversaries of the date of grant. Read SEC document |
| January 31, 2019 Filed Feb 5, 2019 01:40 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 823 | $96.76 | $79,633.48 |
DisclosureSEC source: 0001127602-19-003920 · form4.xml · nonDerivative · entry 2 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,884 Read SEC document |
| January 31, 2019 Filed Feb 5, 2019 01:40 UTC | TD SYNNEX CORP SNX · Entity 8882 | GrantCommon Stock | 2,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-003920 · form4.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,707 F1 · kind: Represents shares issued upon vesting of restricted stock units awarded on January 12, 2016, subject to satisfaction of performance metrics measured over a three-year period ending November 31, 2018. Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 19:26 UTC | TD SYNNEX CORP SNX · Entity 8882 | GrantEmployee Stock Option (Right to Buy) · Derivative | 45,808 | $0.00 Strike: $76.01 | $0.00 |
DisclosureSEC source: 0001127602-18-030137 · form4.xml · derivative · entry 2 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,808 Underlying: Common Stock · 45,808 shares Expires 2028-10-11 F2 · derivative.exercise_date: This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter. Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 19:26 UTC | TD SYNNEX CORP SNX · Entity 8882 | GrantCommon Stock | 7,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-030137 · form4.xml · nonDerivative · entry 1 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,651 F1 · kind: Represents shares of restricted stock awarded under the 2013 Stock Incentive Plan. The restricted stock vests as to 20% of the shares on each of the first five anniversaries of the date of grant. Read SEC document |
| October 08, 2018 Filed Oct 10, 2018 21:50 UTC | TD SYNNEX CORP SNX · Entity 8882 | Tax withholdingCommon Stock | 240 | $83.72 | $20,092.80 |
DisclosureSEC source: 0001127602-18-029925 · form4.xml · nonDerivative · entry 2 Caldwell Christopher A · CIK 0001604279 · President, Concentrix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,416 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.